Cellply is a life-science company focused on developing next-generation analytical tools enabling a deep characterization cancer immunotherapies, cell therapies and cell-based biotherapeutics.
Our goal is to support the development of novel cancer immunotherapies by accelerating the R&D, advancing the quality control and monitoring the clinical response to these treatments.
Through the use of proprietary microfluidic technologies, highly-automated analytical instruments and AI-powered image and data analytics, the Cellply platform defines the function of the immune system one cell at a time, combining functional data with other multiplex data and providing an unprecedented single-cell analytical solution.
Total raised: $6.58M
Founded date: 2013
Investors 3
| Date | Name | Website |
| - | Italian An... | italianang... |
| - | LIFTT | liftt.com |
| - | Indaco Ven... | indacosgr.... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 02.10.2023 | - | $3.82M | - |
| 20.03.2014 | Seed | $2.76M | - |
Mentions in press and media 3
| Date | Title | Description | Source |
| 02.10.2023 | Cellply Raises €3.6M In Funding | Cellply, a Bologna, Italy-based biotech company providing an end-to-end single cell potency characte... | finsmes.co... |
| 29.09.2023 | Bologna-based Cellply secures €3.6 million setting sights on... | - | eu-startup... |
| 20.03.2014 | CellPly Raises €2M in Seed Funding | CellPly, a Bologna, Italy-based innovative startup which specializes in molecular diagnostics, raise... | finsmes.co... |